SEC 13F Intelligence

Bey-Douglas LLC / JNJ

Bey-Douglas LLC’s Johnson & Johnson Position

Does Bey-Douglas LLC own Johnson & Johnson (JNJ)? Yes — 9.8K shares worth $2M (+2.10% of its 13F portfolio) as of Q1 2026, up from 2.2K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
9.8K
% of Portfolio
+2.10%
Quarters Held
10
currently held

Position History JNJ

Reported value by quarter
Q4 ’23: $273,486Q4 ’23Q1 ’24: $288,830Q2 ’24: $273,002Q2 ’24Q3 ’24: $305,861Q4 ’24: $273,444Q4 ’24Q1 ’25: $321,538Q2 ’25: $312,044Q2 ’25Q3 ’25: $394,545Q4 ’25: $459,811Q4 ’25Q1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.8K$2M+2.10%
Q4 20252.2K$459,811+0.37%
Q3 20252.1K$394,545+0.29%
Q2 20252.0K$312,044+0.19%
Q1 20251.9K$321,538+0.29%
Q4 20241.9K$273,444+0.24%
Q3 20241.9K$305,861+0.27%
Q2 20241.8K$273,002+0.25%
Q1 20241.8K$288,830+0.28%
Q4 20231.7K$273,486+0.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bey-Douglas LLC’s full portfolio or all institutional holders of JNJ.